Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · opportunities

FDA Cuts Off Access To Anthropic Version Of Its Elsa AI

21 August 2026 · By · Wire by Fusion42

Published

21 August 2026

Topic

opportunities

◆ Sectors

Healthtech Infrastructure

◆ Geography

United States

◆ Source

Read at insidehealthpolicy.com →

◆ Verified

Fusion42 · 21 August 2026 · Fusion42 review

The FDA will end access to its legacy AI tool Elsa, which was developed in partnership with Anthropic, effective August 24, 2026. This move prioritizes the transition to the updated Elsa 4.0 model, signaling a regulatory shift in government-endorsed AI healthcare tools.

This Wire brief sits within Fusion42's coverage of Healthtech Infrastructure.

◆ ◆ The Wire takeaway

You face a closing window to integrate with the FDA's legacy AI tool before it shuts down on August 24. Switching to Elsa 4.0 now is crucial to maintain compatibility with FDA-endorsed healthcare AI tech.

◆ Coverage

1 source · 21 Aug 2026

◆ Related on Wire

◆ Topics

Healthtech Infrastructurefdaai-healthcareanthropicregulatory-changeelsa-ai